医院培训课件：《Firehawk®冠脉雷帕霉素靶向洗脱支架系统简介》.pptx

Firehawk?冠脉雷帕霉素靶向洗脱支架系统简介(TargetElutingStent,TES)

TARGETClinicalProgramTARGETITrialEnrollmentn=5109moAngioF/U(=80%)1-YearClinicalF/U(=95%)andAnnuallyupto5Years(n=1,010)PrimaryClinicalEndpoint:DeviceOrientedCompositeofCardiacDeath,TVMI,oriTLR(TargetLesionFailure,TLF)at1-Year(ObjectivePerformanceCriteria)LongFIREHAWK(33and38mm)Registry,n=50WorkhorseStent*RandomizedTrialn=460XIENCEVn=230FIREHAWKn=2309moAngioF/U(=80%)FIMEnrollmentn=214moAngio(95%)andOCT(70%)F/UTARGETIIRegistryEnrollmentn=730ClinicalF/UONLY*RVD2.25~4.0mm,LesionLeng